These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 31494063)

  • 21. Rotational Atherectomy Combined with Drug Coated-Balloons for in-Stent Restenosis.
    Allan M; Vickers D; Pitney M; Jepson N
    Cardiovasc Revasc Med; 2019 Jul; 20(7):559-562. PubMed ID: 30217627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients.
    Kawaguchi R; Tsurugaya H; Hoshizaki H; Toyama T; Oshima S; Taniguchi K
    Cardiovasc Revasc Med; 2008; 9(1):2-8. PubMed ID: 18206630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease.
    Nishiyama N; Komatsu T; Kuroyanagi T; Fujikake A; Komatsu S; Nakamura H; Yamada K; Nakahara S; Kobayashi S; Taguchi I
    Int J Cardiol; 2016 Nov; 222():113-118. PubMed ID: 27494722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procedural characteristics and cardiovascular outcomes in patients undergoing drug-coated balloon angioplasty for de novo lesions in large coronary arteries: an observational study.
    Ueda H; Fujiwara Y; Nishida Y; Maenaka M; Yoshimura K; Oshida Y; Matsuhisa S; Yoshida N; Yoshitani H; Kuga Y; Ueda K; Nishida Y
    Heart Vessels; 2024 Jun; 39(6):496-504. PubMed ID: 38411631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
    Uskela S; Kärkkäinen JM; Eränen J; Siljander A; Mäntylä P; Mustonen J; Rissanen TT
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):893-900. PubMed ID: 30380186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients.
    Funayama N; Muratsubaki S; Ito R; Tobisawa T; Konishi T
    Heart Vessels; 2023 Mar; 38(3):300-308. PubMed ID: 36045267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
    Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions.
    Venetsanos D; Lawesson SS; Panayi G; Tödt T; Berglund U; Swahn E; Alfredsson J
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):E317-E326. PubMed ID: 29481718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of angiographic change in side-branch ostium after drug-coated balloon vs. drug-eluting stent vs. medication for the treatment of de novo coronary bifurcation lesions.
    Her AY; Kim B; Kim S; Kim YH; Scheller B; Shin ES
    Eur J Med Res; 2024 May; 29(1):280. PubMed ID: 38735968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery.
    Gitto M; Sticchi A; Chiarito M; Novelli L; Leone PP; Mincione G; Oliva A; Condello F; Rossi ML; Regazzoli D; Gasparini G; Cozzi O; Stefanini GG; Condorelli G; Reimers B; Mangieri A; Colombo A
    Circ Cardiovasc Interv; 2023 Dec; 16(12):e013232. PubMed ID: 37874646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiographic performance of a novel sirolimus-coated balloon in native coronary lesions: the FAtebenefratelli SIrolimus COated NATIVES prospective registry.
    Cortese B; Pellegrini D; Latini RA; Di Palma G; Perotto A; Orrego PS
    J Cardiovasc Med (Hagerstown); 2019 Jul; 20(7):471-476. PubMed ID: 30994510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.
    Kleber FX; Schulz A; Waliszewski M; Hauschild T; Böhm M; Dietz U; Cremers B; Scheller B; Clever YP
    Clin Res Cardiol; 2015 Mar; 104(3):217-25. PubMed ID: 25349065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Long-Term Efficacy of Drug-Coated Balloon Angioplasty following Rotational Atherectomy for Severely Calcified Coronary Lesions Compared with New Generation Drug-Eluting Stents.
    Ueno K; Morita N; Kojima Y; Takahashi H; Kawasaki M; Ito R; Kondo H; Minatoguchi S; Yoshida T; Hashimoto Y; Tatsumi T; Kitamura T
    J Interv Cardiol; 2019; 2019():9094178. PubMed ID: 31772551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial.
    Tang Y; Qiao S; Su X; Chen Y; Jin Z; Chen H; Xu B; Kong X; Pang W; Liu Y; Yu Z; Li X; Li H; Zhao Y; Wang Y; Li W; Tian J; Guan C; Xu B; Gao R;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2381-2392. PubMed ID: 30522667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Drug-Coated Balloons in Native Coronary Artery Disease Left With a Dissection.
    Cortese B; Silva Orrego P; Agostoni P; Buccheri D; Piraino D; Andolina G; Seregni RG
    JACC Cardiovasc Interv; 2015 Dec; 8(15):2003-2009. PubMed ID: 26627997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first.
    Gutiérrez-Chico JL; van Geuns RJ; Koch KT; Koolen JJ; Duckers H; Regar E; Serruys PW
    EuroIntervention; 2011 Oct; 7(6):711-22. PubMed ID: 21986329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Shin ES; Ann SH; Balbir Singh G; Lim KH; Kleber FX; Koo BK
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):193-200. PubMed ID: 26423017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous Coronary Intervention of Complex Calcified Lesions With Drug-Coated Balloon After Rotational Atherectomy.
    Rissanen TT; Uskela S; Siljander A; Kärkkäinen JM; Mäntylä P; Mustonen J; Eränen J
    J Interv Cardiol; 2017 Apr; 30(2):139-146. PubMed ID: 28116778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.